These new findings not only strengthen the early conclusion that ADT with casodex or enzalutamide could increase PCa cell invasion and may also provide a potential new therapeutic approach via interrupting the infiltrating mast cells and their induced lncRNA-HOTAIR-PRC2 complex→AR→MMP9 signals. The gene discussed is HOTAIR; the disease is posterior cortical atrophy.